first_author,year,doi,preprint,protocol,institution_type,institution_names,coi,coi_institutions,funding,funding_institutions,data_url,code_url,disease,disease_category,data_type,data_sources_n,data_geography,missing_method,matching_method,analysis_method,estimand,dag,qba,n_covariates,trts_n,eligible_sample,n_trt,n_ctrl,n_emulations,target_trial_name,target_trial_reg_no,target_trial_doi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Admon,2019,https://doi.org/10.1513/AnnalsATS.201903-241OC,No preprint,http://osf.io/p8cz3,Academic,"University of Michigan, Veterans Affairs Center, Vanderbilt University Medical Center, Louisiana State University School of Medicine, University of Alabama at Birmingham, University of Washington, Ochsner Health System New Orleans, Lahey Hospital and Medical Center",Declared: None,NA,Declared: Public,"U.S. National Heart, Lung, and Blood Institute grants T32HL007749 (A.J.A.), K12HL138039 (J.P.D.), T32HL087738 (J.D.C.), and K23HL143053 (M.W.S.), and by U.S. Department of Veterans Affairs Health Services Research and Development grant 17-045 (T.J.I.).",Unavailable,Unavailable,Hypoxemia,Intensive care,RCTs,3,US,Multiple imputation,PS matching,linear regression,,No,,11,2,360,180,180,,PreVent,NCT03026322,https://doi.org/10.1056/NEJMoa1812405,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Althunian,2020,https://doi.org/10.1002/pds.5065,No preprint,No pre-registration,Academic,"Utrecht University, Dutch Medicines Evaluation Board",Declared: None,NA,Declared: Public,Saudi Food and Drug Authority (SFDA),Unavailable,Unavailable,Atrial fibrilation,Cardiology,National database,1,UK,Multiple imputation,None,Cox PH,,No,,32,2,25473,4008,21465,,Rocket AF,NCT00403767,https://doi.org/10.1056/NEJMoa1009638,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Szummer,2020,https://doi.org/10.1161/circulationaha.120.050645,No preprint,No pre-registration,Academia,"Karolinska Institutet, Stanford University School of Medicine, Linköping University, Lund University, Uppsala University, University of Gothenburg, Sahlgrenska University Hospital",Declared: Financial,"AstraZeneca, Sanofi-Aventis, BMS, Eli-Lilly, MSD, Boeringer-Ingelheim, Novartis, Bayer, Merck","Declared: Public, professional society, NGO","K.S. was supported by the Stockholm County Council (clinical research appointment), by the Swedish Medical Association (Svenska Läkarsällskapet), and by the Swedish Heart Association (Svenska Hjärtförbundet). R.H. was supported by the Stockholm County Council (clinical postdoctoral appointment) and by the Swedish Heart and Lung Foundation. SWEDEHEART is supported by the Swedish Heart and Lung Foundation.",Unavailable,Unavailable,Acture coronary syndrome,Cardiology,Registry,1,Sweden,Multiple imputation,PS matching,Cox PH,ITT,No,,,2,14005,8421,5670,,PLATO,NCT00391872,https://doi.org/10.1056/nejmoa0904327,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Petito,2020,https://doi.org/10.1001/jamanetworkopen.2020.0452,No preprint,No pre-registration,"Academia, Industry","Academia: Harvard T.H. Chan School of Public Health, Brown University, Feinberg School of Medicine-Northwestern University, Massachusetts General Hospital, Harvard Medical School Government: National Cancer Institute Industry: RTI Health Solutions",Declared: Financial,Sanofi Pasteur,"Declared: Public, research institute, NGO","This work was supported by the US National Cancer Institute contract HHSN261201700047 and grant P01-CA134294 (to Drs Petito, García-Albéniz, Logan, and Hernán), and by Patient-Centered Outcomes Research Institute awards ME-1306-03758 and ME-1502-27794 (to Dr Dahabreh). The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; by the Surveillance, Epidemiology and End Results Program of the National Cancer Institute under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute; and by the National Program of Cancer Registries from the Centers for Disease Control and Prevention under agreement U58DP003862-01 awarded to the California Department of Public Health.",Unavailable,Unavailable,Colorectal and pancreatic cancer,Oncology,National Database,1,US,,IPTW,Cox PH,PP,No,,25,,9549,185,6150,,QUASAR,NA,https://doi.org/10.1016/S0140-6736(07)61866-2,NCIC CTG PA.3,NA,https://doi.org/10.1200/jco.2006.07.9525,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Bacic,2020,https://doi.org/10.1016/j.urology.2020.01.039,No preprint,No pre-registration,Academia,"Advance-CTR, Brown University, Rhode Island Hospital, Mayo Clinic, Warren Alpert Medical School of Brown University, Beth Israel Deaconess Medical Center",Declared: None,NA,Declared: Public,"The project described was supported by Institutional Development Award Number U54GM115677 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds Advance Clinical and Translational Research (Advance-CTR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.",Unavailable,Unavailable,Renal cell carcinoma,Oncology,National Database,1,US,Complete case,PS matching,Cox PH,,No,,19,2,67388,58815,8573,,EORTC 30881,NA,https://doi.org/10.1016/j.eururo.2008.09.052,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Kirschgesner,2021,https://doi.org/10.1002/cpt.2304,No preprint,No pre-registration,Academic,"Division of Pharmacoepidemiology and Pharmacoeconomics (Department of Medicine, Brigham and Women's Hospital and Harvard Medical School), Department of Gastroenterology (Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine), Division of Rheumatology, Inflammation, and Immunity (Department of Medicine, Brigham and Women's Hospital and Harvard Medical School)",Declared: Financial,"Roche, Pfizer, Janssen, Allergan, AbbVie, Merck Sharp & Dohme, Ferring Pharmaceuticals, Mayoly-Spendler, Takeda, Tillots, Abbott, Hospira-Pfizer, Boehringer Ingelheim, Bristol-Myers Squibb.",Declared: Research institute,"The investigators conducted the research independently through funding from internal sources of the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School.",Unavailable,Unavailable,Crohn's disease,Gastroenterology,"Claims, national database",3,"US, France",,PS Matching,Log-binomial regression,Not defined,,,27,2,15007,,,,SONIC,NCT00094458,https://doi.org/10.1056/NEJMoa0904492,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Kirschgesner,2021,https://doi.org/10.1002/pds.5356,No preprint,No pre-registration,Academic,"Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique; AP-HP, Hôpital Saint-Antoine",Declared: None,NA,Declared: Research institute,"The investigators conducted the research independently through funding from internal sources of the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School.",Unavailable,Unavailable,Ulcerative colitis,Gastroenterology,"Claims, national database",3,"US, France",,PS Matching,Log-binomial regression,Not defined,,,23,2,22051,,,,UC SUCCESS,NCT00537316,https://doi.org/10.1053/j.gastro.2013.10.052,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthews,2021,https://doi.org/10.1161/jaha.120.020357,https://doi.org/10.1101/2021.02.01.21250739,No pre-registration,Academic,"Karolinska Institutet, Karolinska University Hospital, Harvard T.H. Chan School of Public Health, Uppsala University, Lund University, Skåne University Hospital, Danderyd University Hospital, Harvard-MIT",Declared: Financial,"AstraZeneca, Cytel, ProPublica",Declared: Public,This work was supported by a grant from the Swedish Research Council (registration number 2018-03028).,Unavailable,https://github.com/tonymatthews/validate,Myocardial infarction,Cardiology,Registry,,Sweden,Complete case,IPTW,logistic regression,PP,No,,21,2,4940,2634,2306,,VALIDATE-SWEDEHEART,NCT02311231,https://doi.org/10.1056/nejmoa1706443,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Yiu,2021,https://doi.org/10.1001/jamadermatol.2020.4202,No preprint,No pre-registration,Academic,"University of Manchester, Newcastle University Medical School, Newcastle Hospitals NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust, Salford Royal NHS Foundation Trust",Declared: Financial,"AbbVie, Almirall, Amgen, Arena, Avillion, Bristol Myers Squibb, Boehringer Ingelheim, Celgene, Janssen, LEO Pharma, Lilly, Novartis, Pfizer, Sanofi, Samsung Bioepis, Sandoz Hexal AG, UCB Pharma Ltd","Declared: Public, professional society, private","This research was supported in part by the NIHR Manchester Biomedical Research Centre and the NIHR Newcastle Biomedical Research Centre. Dr Yiu was funded by an NIHR Academic Clinical Lectureship through The University of Manchester. Drs Griffiths and Warren were funded in part by grant MR/L011808/1 from the Medical Research Council. The study group British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) is coordinated by The University of Manchester and funded by the British Association of Dermatologists (BAD). The BAD receives income from AbbVie, Almirall, Amgen, Celgene, Janssen, LEO Pharma, Lilly, Novartis, Samsung Bioepis, Sandoz Hexal AG, and UCB Pharma Ltd for providing pharmacovigilance services. This income finances a separate contract between the BAD and The University of Manchester that coordinate BADBIR. BADBIR acknowledges the support of the NIHR through the clinical research networks and the contribution made by clinical research associates who continue to facilitate recruitment into the registry.",Unavailable,Unavailable,Psoriasis,Immunology,Registry,1,UK and Ireland,Complete case,PS weighted,Generalized linear models with a log link,,No,,18,2,1231,314,917,,CLEAR,NCT02074982,"https://doi.org/10.1016/j.jaad.2015.05.013, https://doi.org/10.1016/j.jaad.2016.08.008",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Weberpals,2021,https://doi.org/10.1097/ede.0000000000001338,No preprint,No pre-registration,"Industry, Academia","Roche Innovation Center Munich (industry), xValue GmbH (industry), F. Hoffmann-La Roche Ltd (industry), German Research Center for Environmental Health - Helmholtz Center Munich (academia), Technical University of Munich (academia)",Declared: Financial,"Roche, xValue, Roche Diagnostics GmbH, Cellarity Inc.",Delcared: Private,This work was funded by Roche as part of the main authors (J.W.) postdoctoral fellowship program (RPF-ID: 498).,Unavailable,https://github.com/theislab/autoencoderPS,Advanced non-small cell lung cancer,Oncology,EMR,1,US,Median imputation and assigning a missing-indicator category,1:1 PS matching,Cox PH,,No,,441,2,781,,,,PRONOUNCE,NCT00948675,https://doi.org/10.1097/jto.0000000000000366,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Jang,2022,https://doi.org/10.3390/ijerph192013560,No preprint,No pre-registration,Academic,"College of Pharmacy and Research Institute of Pharmaceutical Sciences at Seoul National University, and Department of Internal Medicine at Seoul National University Hospital",Declared: None,NA,Declared: Public,This research was supported by a grant (2020MFDS171) from the Ministry of Food and Drug Safety in 2020.,Unavailable,Unavailable,Relapsed/refractory multiple myeloma,Oncology,"EHRs, clinical data warehouse",2,South Korea,,"PS Matching, 1:1 matching",Cox PH,Not defined,No,,9,2,263,69,69,,ASPIRE,NCT01080391,https://doi.org/10.1056/nejmoa1411321,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthews,2022,https://doi.org/10.1093/aje/kwac098,No preprint,No pre-registration,Academic,"Karolinska Institutet, Harvard T.H. Chan School of Public Health, Örebro University Hospital, Uppsala University, Danderyd University Hospital-Karolinska Institutet",Declared: Financial,"Sanofi Pasteur, Cytel, ProPublica","Declared: Public, research institute, NGO","This work was supported by a grant from the Swedish Research Council (2018-03028). A.A.M. received funds from the Strategic Research Program in Epidemiology at Karolinska Institutet, Forte (2020-00029), and Swedish Research Council (2021-02236). I.J.D. received funds from the Patient-Centered Outcomes Research Institute (PCORI; ME-1502-27794) during the conduct of the study.",Unavailable,https://github.com/tonymatthews/taste,Myocardial infarction,Cardiology,Registry,1,Sweden,Complete case,Not defined,Cox PH,PP,No,,24,2,18222,3462,14760,,TASTE,NCT01093404,"https://doi.org/10.1056/NEJMoa1308789, https://doi.org/10.1056/NEJMoa1405707",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Kuehne,2022,https://doi.org/10.1016/j.jclinepi.2022.10.005,No preprint,No pre-registration,"Academic, Industry","Academia (UMIT TIROL University, Technical University Dresden, Innsbruck Medical University, Harvard T.H. Chan School of Public Health, Massachusetts General Hospital), Industry (Eli Lilly and Company), and Health Services (Cancer Registry Tyrol)",Declared: Financial,Eli Lilly and Company,"Declared: Public, private",This work was supported by independent research grant by Lilly Research Award Program (LRAP) and partly funded by the state Tyrol (grant number F.16731/5-2019).,Unavailable,Unavailable,Ovarian cancer,Oncology,EMR/Hospitals,1,US,,,Cox PH,PP,Yes,,4,2,1582,1582,1582,,MRC OV05/EORTC 55955,ISRCTN87786644,https://doi.org/10.1016/S0140-6736(10)61268-8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Barbulescu,2022,https://doi.org/10.1002/cpt.2673,No preprint,https://clinicaltrials.gov/study/NCT05051137,Academic,"Karolinska Institutet, Karolinska University Hospital, University of Iceland, Brigham and Women's Hospital/Harvard Medical School",Declared: Financial,"AbbVie, Bristol Myers Squibb, MSD, Eli Lilly, Pfizer, Roche, Samsung Bioepis, UCB, Roche/Genentech, deCODE genetics",Declared: Public,This work was supported by the Swedish Research Council (grant 2016-01355). S.C.K. is supported by the National Institutes of Health (NIH; grant K24AR078959),Unavailable,Unavailable,Rheumatoid Arthritis,Rheumatology,National database,,Sweden,Multiple imputation,IPTW,logistic regression,Not defined,No,,32,2,509,313,196,,SWEFOT,CT20080004,https://doi.org/10.1016/s0140-6736(09)60944-2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Jin,2022,https://doi.org/10.1016/j.joca.2022.06.005,No preprint,No pre-registration,Academic,"University of New South Wales, University of Sydney, Southern Medical University, University of Tasmania",Declared: Financial,"Pfizer, Lilly, Novartis, Merck Serono, TLCBio, Kolon Tissuegene",Declared: Public,"XJ received salary support from an NHMRC Early Career Fellowship (1104600), and DJH received salary support an NHMRC Investigator Grant (1194737). There are no other funding sources for this study.",Unavailable,Unavailable,Osteoarthritis,Rheumatology,Registry,1,US,Complete case,IPTW,Hierarchical linear mixed models,ITT,No,,12,2,5419,237,1329,,Sanghi et al,NA,https://doi.org/10.1007/s11999-013-3201-6,McAlindon et al.,NCT00306774,https://doi.org/10.1001/jama.2012.164487,Arden et al.,ISRCTN94818153,https://doi.org/10.1016/j.joca.2016.05.020,Jin et al.,NCT01176344,https://doi.org/10.1001/jama.2016.1961,Sanghi et al,NA,https://doi.org/10.1007/s11999-013-3201-6,McAlindon et al.,NCT00306774,https://doi.org/10.1001/jama.2012.164487,Arden et al.,ISRCTN94818153,https://doi.org/10.1016/j.joca.2016.05.020,Jin et al.,NCT01176344,https://doi.org/10.1001/jama.2016.1961,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Chen,2022,https://doi.org/10.1200/cci.21.00195,No preprint,No pre-registration,Academic,"University of Florida, Cornell University, Duke University, Wake Forest School of Medicine",Declared: Financial,"Tempus, Pfizer, Bristol Myers Squibb, Merck, AstraZeneca/MedImmune, Lilly, Bayer, Incyte, Ipsen, Seattle Genetics, Genentech, Astellas Pharma, BioMed Valley Discoveries, GlaxoSmithKline, Amgen, OncoC4, IBM, Boehringer Ingelheim, Synyi Tech, Air Liquide, Sanofi, Johnson & Johnson, Gilead Sciences, Celgene, Athenex",Declared: Public,Supported by National Cancer Institute R21CA253394; National Cancer Institute R01CA246418.,Unavailable,Unavailable,Colorectal Cancer,Oncology,Registry,1,US,,PS matching,Cox PH,,No,,4,2,49948,,,2,Cutsem et al.,NCT00154102,https://doi.org/10.1200/jco.2010.33.5091,Peeters et al.,NCT00339183,https://doi.org/10.1158/1078-0432.ccr-15-0526,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Hou,2022,https://doi.org/10.1001/jamanetworkopen.2022.18371,No preprint,No pre-registration,"Industry, Academia","Harvard T. H. Chan School of Public Health, University of British Columbia, Brigham and Women's Hospital/Harvard Medical School, Merck & Co, Inc",Declared: Financial,"Merck & Co, Inc.","Declared: Public, private","The study was supported by Merck & Co, Inc; by grants P30 AR072577 (Dr Liao) and K99NS114850 (Dr Beaulieu-Jones) from the National Institutes of Health (NIH); and grant U01CA209414 from the National Cancer Institute of the NIH (Dr Christiani).",Unavailable,https://github.com/hjmarquis/REST_paper1,Colorectal Cancer,Oncology,EMR,1,US,Complete case,PS matching,Cox PH,,No,,8,2,943,518,425,,COST,NCT00002575,https://doi.org/10.1056/NEJMoa032651,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Jang,2022,https://doi.org/10.3389/fphar.2022.928121,https://doi.org/10.21203/rs.3.rs-1362085/v1,No pre-registration,Academia,Seoul National University,Declared: None,NA,Declared: Public,This research was supported by a grant (20173MFDS171) from the Ministry of Food and Drug Safety in 2020.,Unavailable,Unavailable,Major adverse cardiovascular events in diabetes,Cardiology,National database,1,South Korea,1:1 matching,"Cox PH, logistic regression",ITT,,No,,72,,48545,11563,11563,,EMPA-REG OUTCOME,NCT01131676,https://doi.org/10.1056/NEJMoa1504720,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Merola,2022,https://doi.org/10.2147/CLEP.S373291,No preprint,No pre-registration,"Academia, Industry","Brigham and Women's Hospital, Harvard Medical School, Harvard TH Chan School of Public Health, Harvard Pilgrim Healthcare Institute, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical School, Massachusetts General Hospital, Ontada",Declared: Financial,"Aetion Inc, McKesson Corporation, Boehringer Ingelheim, JAMA, GRAIL, Dana-Farber Cancer Institute",Declared: NGO,This project was funded by an Innovation in Regulatory Science Award from the Burroughs Wellcome Fund (#1020021).,Unavailable,Unavailable,Breast cancer,Oncology,EMR,1,US,Multiple imputation,Stratification,Cox PH,,No,,18,,1886,462,1424,,PARSIFAL,NCT02491983,https://doi.org/10.1001/jamaoncol.2021.4301,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Softness,2022,https://doi.org/10.1016/j.urolonc.2021.12.015,No preprint,No pre-registration,Academic,"Beth Israel Deaconess Medical Center, Massachusetts General Hospital, University of Colorado",Declared: None,NA,Not declared,NA,Unavailable,Unavailable,Bladder cancer,Oncology,National database,1,US,Complete case,IPTW,Cox PH,,No,,16,,2048,1812,236,,SPARE,ISRCTN61126465,https://doi.org/10.1111/bju.13900,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Evans,2023,https://doi.org/10.1371/journal.pone.0268807,No preprint,No pre-registration,Academia,"University of Bristol, North Bristol NHS Trust",Declared: None,NA,"Declared: Public, NGO","This National Institute for Health Research (NIHR) Programme Grants for Applied Research funded the BSI-FOO and RAPIDO studies (RP-PG-0707-10043). The British Heart Foundation and NIHR Bristol Biomedical Research Unit for Cardiovascular Disease and North Bristol Charitable Funds funded some staff time (JH, CR, RE).",https://doi.org/10.5523/bris.2jpy7mh519ono2exurvl84zwzl,Unavailable,Blood infection,Hematology,Cohort,1,UK,Conditional mean imputation,PS matching,Logistic regression,PP,No,,11,2,163,82,39,,MERINO,NCT02176122,https://doi.org/10.1001/jama.2018.12163,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Gallivan,2023,https://doi.org/10.3928/23258160-20221214-01,No preprint,No pre-registration,"Academia, Industry","Verana Health (industry), American Academy of Ophthalmology (professional organization), Department of Ophthalmology, Byers Eye Institute at Stanford, Stanford University School of Medicine (academia)",Declared: Financial,"Verana Health, Roche/Genentech, Protagonist Therapeutics, Graybug, Apellis, Regeneron, Astellas, Nanoscope","Declared: Public, private, NGO","Supported in part by Verana Health, the National Institutes of Health Core Grants for Vision Research P30-EY026877 (TL), and unrestricted funds from Research to Prevent Blindness (TL). The funding organization, Verana Health, participated in the design of the study; conducting the study; data collec- tion; data management; data analysis; interpretation of the data; and preparation, review, or approval of the manuscript. The views expressed herein are those of the authors and do not necessarily reflect the policies or opinions of the American Academy of Ophthalmology.",Unavailable,Unavailable,Neovascular age-related macular degeneration,Opthalmology,EMR,1,Ireland,Complete case,inverse-odds-of-sampling,ANOVA,,No,,4,,90900,1783,2520,,VIEW 1,NCT00509795,"https://doi.org/10.1016/j.ophtha.2012.09.006, https://doi.org/10.1136/bjophthalmol-2019-315021",VIEW 2,NCT00637377,"https://doi.org/10.1016/j.ophtha.2012.09.006, https://doi.org/10.1136/bjophthalmol-2019-315021",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Jiao,2023,https://doi.org/10.1093/aje/kwad091,No preprint,No pre-registration,Academia,"Lady Davis Institute, Jewish General Hospital, McGill University, Charité—Universitätsmedizin Berlin, University of Florida",Declared: Financial,"Amgen, Analysis Group, Biogen, Merck, Nant Pharma, Pfizer, and Reckitt Benckiser","Declared: Public, research institute, private","This project was funded by Canadian Institutes of Health Research (CIHR; grant number CIHR-425772). A.D., R.W.P., and K.B.F. report grants from the CIHR, outside of the submitted work. A.D. is supported by a salary support award from the Fonds de recherche du Québec—santé (FRQS; Quebec Foundation for Research—Health). R.W.P. holds the Albert Boehringer I Chair in Pharmacoepidemiology. K.B.F. is supported by a salary support award from the FRQS and holds a William Dawson Scholar award from McGill University.",Unavailable,https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/aje/192/9/10.1093_aje_kwad091/2/web_material_kwad091.pdf?Expires=1736999493&Signature=aqy6N6SGe8OIgbfLE~LNbEvj6BTz319fd~933FaOSarNoO49pkP6-HcpW237TsaM5gfJFaELELp1mUeA7op2A03JYXsaCf0GX0S5hLxVQJC0hmKiuieGdszxolowI1wU1sQSe8W6cJ0UUyqGfCSYDP4S6Op2Az4Oe4WVanQLjZ1X3JQktZDjaBPz6~P-iZfcKA56bdcmJdK-EbgGfivmMtyNYkeF4kUEyGqio-pcbcPV~4-vOJrp525GW~Vt9Y-NssPlGXbRpKVaJL-IELRuj1ekiOwTExV1k8miaAieh7Z-sj-Bf9dHvMK-CborKpl6~vefi64rOmSKv79W0Me-Yw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA#page=2.08,Blood pressure control,Cardiology,National database,1,UK,LOCF and multiple imputation,IPTW and IPCW,Cox PH,PP,No,,18,,103708,1860,2550,,SPRINT,NCT01206062,https://doi.org/10.1056/NEJMoa1511939,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Merola,2023,https://doi.org/10.1002/pds.5565,No preprint,No pre-registration,"Academia, Industry","Brigham and Women's Hospital, Harvard Medical School, Harvard TH Chan School of Public Health, Harvard Pilgrim Health Care Institute, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical School, Massachusetts General Hospital, Avalere Health",Declared: Financial,"Boehringer Ingelheim, Aetion Inc., McKesson Corporation",Delcared: NGO,This project was funded by an Innovation in Regulatory Science Award from the Burroughs Wellcome Fund (#1020021).,Unavailable,Unavailable,Breast cancer,Oncology,EMR,1,US,Multiple imputation,Stratification,Cox PH,,No,,28,,3836,1299,2537,,PALOMA-2,NCT01740427,https://doi.org/10.1007/s10549-018-05125-4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Wakabayashi,2023,https://doi.org/10.1007/s40801-023-00353-7,No preprint,No pre-registration,"Academia, Industry","linical Study Support, Inc., Nagoya, Japan, Real-World Evidence and Data Assessment (READS), Graduate School of Medicine, Juntendo University, Department of Radiology, School of Medicine, Juntendo University",Declared: Financial,Clinical Study Support Inc.,"Declared: Research institute, private","This study was conducted as part of a joint research course (Real-World Evidence and Data Assessment) between Juntendo University and Shin Nippon Biomedical Laboratories, Ltd.",Unavailable,Unavailable,Diabetes,Endocrinology,Claims/EMR,1,Japan,,1:1 PS nearest-neighbor matching,t-distribution,ITT,No,,4,,96,48,48,,PRIME-V,UMIN000015170,https://doi.org/10.1111/dom.13750,COMPASS,UMIN000004716,https://doi.org/10.1111/dom.12055,Onishi 2013 et al.,NCT01272193,https://doi.org/10.1111/dom.12097,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Robak,2024,https://doi.org/10.1080/03007995.2024.2368175,No preprint,No pre-registration,"Academia, Industry","Medical University of Lodz, University Hospital Brno, Hôpital Lyon-Sud, Janssen Pharmaceutica NV, UAB ""JOHNSON & JOHNSON"", Janssen-Cilag GmbH, Janssen Sciences Ireland UC, Pharmacyclics",Declared: Financial,"Janssen, AbbVie, AstraZeneca, BeiGene, Lilly, AOP Orphan, Gilead",Declared: Private,"The study was funded by Janssen Pharmaceutica NV and Pharmacyclics LLC, an AbbVie Company. The real-world databases in France and the Czech Republic (Lyon-Sud and CLLEAR) that were utilized are not owned by Janssen Pharmaceutica NV.",Unavailable,Unavailable,Chronic lymphocytic leukemia,Oncology,EMR/Registry/Trial,2,"Czech Republic, France",,PS matching,Cox PH,,No,,18,2,1360,119,692,3,RESONATE-2,NCT01722487,"https://doi.org/10.1056/nejmoa1509388, https://doi.org/10.3324/haematol.2018.192328",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Baptiste,2024,https://doi.org/10.1093/aje/kwae137,https://doi.org/10.1101/2022.12.02.22282220,https://doi.org/10.1136/bmjopen-2021-051907,"Academia, Industry","London School of Hygiene & Tropical Medicine, Queen Mary University of London, Friedrich Alexander University, McMaster University, Analysis Group Inc.",Declared: Financial,"GSK, Compass Pathways, Ontario Ministry of Health, Sanofi, Pfizer, Leo Pharma, Astellas, Janssen, Amgen, Boehringer-Ingelheim, Baxter, Fresenius Medical Care, AstraZeneca, Vifor Fresenius Medical Care, Relypsa, Bayer HealthCare, Novo Nordisk, UpToDate Inc., Idorisia, Labchem, Parexel, Roche","Declared: Private, research institute, NGO","This work was supported by the funding from a GlaxoSmithKline PhD studentship held by PB as part of an ongoing collaboration between GSK and the London School of Hygiene and Tropical Medicine. This research was funded in whole, or in part, by the Wellcome Trust [Senior Research Fellowship 224485/Z/21/Z to EW]. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.",Unavailable,Unavailable,Cardiovascular disease,Cardiology,EMR,3,UK,Multiple imputation,PS matching,Cox PH,,No,,39,2,137155,40553,96602,1,ONTARGET,NCT00153101,https://doi.org/10.1056/NEJMoa0801317,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Goriacko,2024,https://doi.org/10.1093/ajhp/zxae161,No preprint,No pre-registration,Academia,"Montefiore Medical Center, Albert Einstein College of Medicine, Carolinas Medical Center ",Declared: None,NA,Declared: Public,"Financial support for this study was provided in part by a grant from the Agency for Healthcare Research and Quality (K12HS026396). The funder had no role in designing the study, interpreting the data, or writing or publishing the report.",Unavailable,Unavailable,COVID-19,Infectious diseases,EHR,1,US,,Coarsened exact matching,Logistic regression,"ITT, PP",Yes,,,2,3293,244,472,2,REMAP-CAP,NCT02735707,https://doi.org/10.1056/NEJMoa2100433,RECOVERY,NCT04381936,https://doi.org/10.1056/NEJMoa2021436,WHO Meta-analysis,NA,https://doi.org/10.1001/jama.2020.17023,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Szmulewicz,2024,https://doi.org/10.1093/aje/kwae029,No preprint,No pre-registration,Academia,"Harvard T.H. Chan School of Public Health, Yale School of Medicine, University of Pittsburgh, University of British Columbia, New York University Grossman School of Medicine, Hospital General Universitario Gregorio Marañón, McLean Hospital, Harvard Medical School",Declared: None,NA,Declared: NGO,A.G.S. was partly supported by a 2022 NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation.,Unavailable,Unavailable,Psychosis,Psychology,"Cohorts, EHR",8,"US, Canada, Spain",,IPTW,"Cox PH, Logistic regression",PP,No,,13,6,1123,853,383,,EUFEST,ISRCTN68736636,https://doi.org/10.1016/S0140-6736(08)60486-9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Signori,2024,https://doi.org/10.1136/jnnp-2023-332603,No preprint,No pre-registration,Academia,"University of Genova, University of Melbourne, Dokuz Eylul University, Charles University, Amiri Hospital, University of Catania, University Hospital Basel, Hospital Universitario Virgen Macarena, American University of Beirut Medical Center, Hacettepe University, Hotel-Dieu de Levis, Université de Montréal, Monash University, Alfred Hospital, Ospedale Policlinico San Martino",Declared: Financial,"Chiesi, BMS, Roche, Janssen, Sanofi Genzyme, Novartis, Merck, Biogen, WebMD Global, Eisai, BioCSL, Celgene, Teva, Bayer, GSK, Almirall, EMD Serono, Alexion, CSL, Pendopharm, Geneuro, Immunic, Medday",Declared: None,"The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-­for-profit sectors.",Unavailable,Unavailable,Multiple sclerosis,Neurology,Registry,1,"Italy, Australia, Turkey, Czech Republic, Kuwait, Switzerland, Spain, Lebanon, Canada",,1:1 PS matching,"Negative binomial regression, standard and ordinal logistic regression, linear regression",,No,,7,2,4376,3236,1140,1,TRANSFORMS,NCT00340834,https://doi.org/10.1056/NEJMoa0907839,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthews,2024,https://doi.org/10.1007/s10654-024-01119-3,No preprint,No pre-registration,Academia,"Karolinska Institutet, Harvard T.H. Chan School of Public Health, Uppsala University, Lund University",Declared: Financial,"Bristol Myers Squibb/Pfizer, Cytel, ProPublica, ADIA Lab, Flatiron and Foundation Medicine","Declared: Research institute, NGO","Open access funding provided by Karolinska Institute. This research was also supported in part by Patient-Centered Outcomes Research Institute (PCORI) Methods Research Award ME-2021C2-22365 (the manuscript does not reflect the views of PCORI, PCORI’s Board of Governors, or the PCORI Methodology Committee).",Unavailable,https://github.com/tonymatthews/reduce,Myocardial infarction,Cardiology,Registry,5,Sweden,Median,IPTW,Logistic regression,"ITT, PP",No,,40,2,10926,9728,1198,1,REDUCE-AMI,NCT03278509,https://doi.org/10.1093/ehjcvp/pvac070,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Wang,2023,https://doi.org/10.1001/jama.2023.4221,No preprint,"NCT03936049, NCT04215523, NCT04215536, NCT03936010, NCT03936036, NCT03936062, NCT03936023, NCT05162183, NCT04237922, NCT04237935, NCT05086081, NCT04593030, NCT04593043, NCT04593056, NCT04736420, NCT04879407, NCT04735523, NCT04736719, NCT05083455, NCT04354376, NCT04354350, NCT04736693, NCT04879420, NCT04882813, NCT04736433, NCT04892758, NCT04892732, NCT05062304, NCT05083429, NCT05179512, NCT03648424, NCT04897958","Academia, Industry","Brigham and Women's Hospital, Harvard Medical School, McGill University, Vanderbilt University, Stanford University, Duke University, US Food and Drug Administration, Optum, Aetion Inc, AbbVie Inc, Moderna",Declared: Financial,"Aetion Inc, UCB Pharma, Boehringer Ingelheim, Alosa Health, Blue Cross Blue Shield, Amarin, Kowa, Novartis, Pfizer, AstraZeneca, Atara, Bristol Myers Squibb, Panalgo, Merck, Seqirus",Declared: Public,"This DUPLICATE Initiative was funded by contracts from the U.S. Food and Drug Administration (HHSF223201710186C and HHSF223201810146C) to the Brigham and Women's Hospital (PI Dr. Schneeweiss and Wang). Drs. Wang and Schneeweiss were further supported by funding from the National Institutes of Health RO1HL141505, R01AG053302, and R01AR080194. The content is solely the responsibility of the authors and does not necessarily represent the official views of the U.S. Food and Drug Administration.",Unavailable,Unavailable,"Multiple conditions including cardiovascular outcomes, diabetes, antiplatelet agents, anticoagulants, hypertension, osteoporosis, kidney disease, heart failure, asthma, COPD, and prostate cancer",All areas,Claims,3,US,,PS matching,Cox PH,,No,,100,,,,,32,LEADER,NCT01179048,https://doi.org/10.1007/s13300-018-0524-z,DECLARE-TIMI58,NCT01730534,https://doi.org/10.1056/nejmoa1812389,EMPA-REG,NCT01131676,https://doi.org/10.1056/nejmoa1504720,CANVAS,NCT01032629,https://doi.org/10.1056/nejmoa1611925,CARMELINA,NCT01897532,https://doi.org/10.1001/jama.2018.18269,TECOS,NCT00790205,https://doi.org/10.1056/nejmoa1501352,SAVOR-TIMI,NCT01107886,https://doi.org/10.1056/nejmoa1307684,LEAD-2,NCT00318461,https://doi.org/10.2337/dc08-1355,TRITON-TIMI,NCT00097591,https://doi.org/10.1056/nejmoa0706482,PLATO,NCT00391872,https://doi.org/10.1056/nejmoa0904327,ISAR-REACT 5,NCT01944800,https://doi.org/10.1056/nejmoa1908973,ARISTOTLE,NCT00412984,https://doi.org/10.1056/nejmoa1107039,RE-LY,NCT00262600,https://doi.org/10.1056/nejmoa0905561,ROCKET AF,NCT00403767,https://doi.org/10.1056/nejmoa1009638,EINSTEIN DVT,NCT00440193,https://doi.org/10.1056/nejmoa1007903,EINSTEIN PE,NCT00439725,https://doi.org/10.1056/nejmoa1007903,RE-COVER II,NCT00680186,https://doi.org/10.1161/circulationaha.113.004450,AMPLIFY,NCT00643201,https://doi.org/10.1056/nejmoa1302507,RECORD1,NCT00329628,https://doi.org/10.1056/nejmoa0800374,TRANSCEND,NCT00153101,https://doi.org/10.1016/s0140-6736(08)61242-8,ONTARGET,NCT00153101,https://doi.org/10.1056/nejmoa0801317,HORIZON-PFT,NCT00049829,https://doi.org/10.1056/nejmoa067312,VERO,NCT01709110,https://doi.org/10.1016/s0140-6736(17)32137-2,DAPA-CKD,NCT03036150,https://doi.org/10.1056/nejmoa2024816,PARADIGM-HF,NCT01035255,https://doi.org/10.1056/nejmoa1409077,P04334,NCT00383240,https://doi.org/10.2500/aap.2010.31.3364,D5896,NCT01444430,https://doi.org/10.1056/nejmoa1511190,IMPACT,NCT02164513,https://doi.org/10.1056/nejmoa1713901,POET-COPD,NCT00563381,https://doi.org/10.1056/nejmoa1008378,INSPIRE,NCT00361959,https://doi.org/10.1164/rccm.200707-973oc,CAROLINA,NCT01243424,https://doi.org/10.1001/jama.2019.13772,PRONOUNCE,NCT02663908,https://doi.org/10.1161/circulationaha.121.056810